Treatments for Improving Mood in Depressed Teens-3
TeenThrive
Adaptation and Pilot Study of Yoga to Reduce Depression in Adolescents
2 other identifiers
interventional
30
1 country
1
Brief Summary
Phase 3 is a randomized clinical trial of yoga vs group Cognitive Behavioral Therapy (CBT) for adolescents with depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2019
CompletedFirst Posted
Study publicly available on registry
February 5, 2019
CompletedStudy Start
First participant enrolled
October 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2021
CompletedResults Posted
Study results publicly available
June 2, 2022
CompletedJune 2, 2022
May 1, 2022
1.9 years
January 30, 2019
March 29, 2022
May 9, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Acceptability
Acceptability is operationalized by the number of participants who attended 8 or more classes out of possible 12. Target was 70% or greater.
12 weeks
Credibility Expectancy Questionnaire (CEQ) - Credibility Subscale
Credibility assessed with Credibility Expectancy Questionnaire (CEQ), credibility subscale. The credibility subscale of the CEQ, is a 3 item subscale of the 6 item CEQ. The 3 items are each scored on a range of 0-1, and the mean of thise is used in analyses. Higher scores indicate greater credibility.
Week 1
Credibility Expectancy Questionnaire (CEQ) - Expectancy Subscale
Patient expectations assessed with the Credibility Expectancy Questionnaire (CEQ), expectancy subscale. The expectancy subscale is a 3 item subscale of the 6 item CEQ. Score ranges from 0-1 and the mean of those scores are analyzed, with higher scores indicating greater expectations.
Week 1
The Client Satisfaction Questionnaire (CSQ-8)
Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.
Post intervention (month 3)
Home Practice Questionnaire
Number of participants who met criteria for home practice (target of two practices per week) as assessed with a home practice questionnaire.
Post intervention (month 3)
Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)
Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.
Post intervention (month 3)
Secondary Outcomes (1)
Quick Inventory of Depression - Adolescent Version - Clinician Rating (QIDS-A-CR)
Baseline to post intervention (month 3)
Study Arms (2)
Hatha Yoga
EXPERIMENTAL12 weeks of hatha yoga
Group CBT
EXPERIMENTAL12 weeks of group CBT
Interventions
Eligibility Criteria
You may qualify if:
- Adolescents must have elevated depressive symptoms, defined by a score of 10 or higher on the Quick Inventory of Depression -Adolescent Version-- Clinician Rating (QIDS-A-CR), including endorsement of either sad mood or anhedonia on the QIDS.
- Other treatment for depression must be stable at baseline. Adolescents do not have to be in other treatment for depression, but, if they are, it must be stable for the past 8 weeks.
- Adolescents must be aged 13-18.
- Adolescents must be medically cleared for moderate physical activity by their primary care physician. This criterion may be met by a current (dated in the past year) statement from their pediatrician that the adolescent may participate in school or camp programs including physical education.
- Adolescents must be able to read and write English sufficient to complete informed consent and engage in interventions.
- Adolescents aged 13-17 must assent to be in the study, and their parent or legal guardian must consent to their participation. Adolescents aged 18 must consent to be in the study.
- Able to attend one of the class times.
You may not qualify if:
- QIDS- A-CR may not be higher than a score of 21. This ensures that adolescents are not severely depressed.
- Adolescents may not meet criteria for the following:
- Autism spectrum disorder "cannot be ruled out", and symptoms are of sufficient severity to interfere with study treatment per clinician judgement
- Current psychotic disorder
- Lifetime history of a manic episode
- Anorexia or Bulimia in past 3 months
- Substance use disorders in past 12 months, and symptoms are of sufficient severity to interfere with study treatment per clinician judgment These will be assessed with the Mini-International Neuropsychiatric Interview (MINI).
- Adolescents may not have suicide ideation so severe it will interfere with study participation.
- Adolescents cannot currently be engaged in yoga classes, as this is the study intervention.
- Adolescents cannot be pregnant as yoga should be modified for pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- National Center for Complementary and Integrative Health (NCCIH)collaborator
- Butler Hospitalcollaborator
Study Sites (1)
Butler Hospital
Providence, Rhode Island, 02906, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Lisa Uebelacker
- Organization
- Butler Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa Uebelacker, PhD
Butler Hospital
- PRINCIPAL INVESTIGATOR
Shirley Yen, PhD
Brown University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2019
First Posted
February 5, 2019
Study Start
October 21, 2019
Primary Completion
September 29, 2021
Study Completion
September 29, 2021
Last Updated
June 2, 2022
Results First Posted
June 2, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- upon study completion
- Access Criteria
- PIs will review requests for IPD.
IPD will be made available to other researchers upon request.